Wu Hero 04

Wu’s Journey

Actual patient. Individual results may vary

I tried so many different ways to keep ‘up’ my face but I still looked ‘down’. A year after ELLANSÉ it felt fantastic to be told by friends that I looked much younger than my true age. My face looked more defined and contoured, and my skin texture felt so much younger. - Wu

See Wu's transformational result

Before

After

The before & after

3D mapping – How Wu’s results were achieved

In the upper face, the images show a more enhanced eyebrow shape and a better contour of the glabella, along with vertical and horizontal lifting of the eyebrows and eyelids which is the result of volumisation in the ROOF.

3D Journey

In the midface, a downward sliding of the soft tissue seen as ptosis of deep fat compartments and jowls has been corrected, coupled with a rejuvenated anterior projection after volume restoration in the premaxillary spaces and the deep fat compartments.

After 3D.

In the midface, a downward sliding of the soft tissue seen as ptosis of deep fat compartments and jowls has been corrected, coupled with a rejuvenated anterior projection after volume restoration in the premaxillary spaces and the deep fat compartments.

Meet WU’s Physician

B&A Web Wu A

INDICATION:

The EU approved intended use is: Ellansé (a Poly-ɛ-caprolactone-based dermal filler) is an injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial aging signs or conditions.

INDICATION:

The EU approved intended use is: Ellansé (a Poly-ɛ-caprolactone-based dermal filler) is an injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial aging signs or conditions.

Important Safety Considerations:

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction (redness, swelling, rash, oedema, erythema, lumps/nodules etc.), pain (which may be temporary or persistent in nature), transient haematoma or bruising.

Other potential adverse events include

- Injection related reactions, include itching, discoloration or tenderness may occur at the site of the injection. These usually resolve spontaneously within several days after the injection.

- As with any implant material possible adverse reactions that may occur include, but are not limited to the following: hypersensitivity, allergic reactions, inflammation, infection, fistula formation, haematoma, seroma, extrusion, induration formation, inadequate healing, skin discoloration, oedema, contusions/bruises, ecchymosis, inadequate or excessive augmentation, loss of correction, interference with local circulation if injected into a blood vessel resulting in vessel laceration, occlusion, embolism, infarction, and abscess at implant site which may result in induration and/or scar formation.

- Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage, leading to stroke, skin necrosis, damage to underlying facial structures, nausea and vomiting, lack of ocular movement, significant skin changes, ptosis, exotropia and neurological complications.

- Adverse events, other than mentioned above, could occur as can be with any medical intervention.

All (potential) adverse side effects and incidents should be reported immediately to the Sinclair Corporate Safety Group: quality@sinclair.com

For a full list of contraindications, warnings, and precautions for this product please visit http://www.sinclairpharma.com/eifu/ for a copy of the Product Instructions for Use.